Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2007-01-12
2010-11-16
Bunner, Bridget E (Department: 1647)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S320100, C435S325000, C435S471000, C536S023500, C530S351000
Reexamination Certificate
active
07833754
ABSTRACT:
The present invention provides for nucleic acids improved for the expression of interleukin-12 (IL-12) in mammalian cells. The invention further provides for methods of expressing IL-12 in mammalian cells by transfecting the cell with a nucleic acid sequence encoding an improved IL-12 sequence.
REFERENCES:
patent: 5922685 (1999-07-01), Rakhmilevich et al.
patent: 2003/0181405 (2003-09-01), Nordstrom et al.
patent: WO 98/17814 (1998-04-01), None
patent: WO 99/47678 (1999-09-01), None
patent: WO 2005/118874 (2005-12-01), None
Crystal R, Science, 1995. vol. 270, pp. 404-410.
Anderson W, Nature, 1998. vol. 392, pp. 25-30.
Verma et al. Nature, 1997. vol. 389, p. 239-242, col. 3, paragraph 2.
Gabor M. Rubanyi , Mol Aspects Med , 2001 vol. 22, pp. 113-142.
Jayaray et al., “GeMS: an advanced software package for designing synthetic genes,” 2005, Nucleic Acids Res.,; 33: 3011-3016.
Felber Barbara
Pavlakis George N.
Rosati Margherita
Bunner Bridget E
Hamud Fozia M
The United States of America as represented by the Secretary of
Townsend and Townsend / and Crew LLP
LandOfFree
IL-12 for expression in mammalian cell does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with IL-12 for expression in mammalian cell, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and IL-12 for expression in mammalian cell will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4248447